Cone-beam CT Guided Microcoil Localization of Pulmonary Nodules During Video Assisted Thoracic Surgery(VATS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02496624 |
Recruitment Status :
Recruiting
First Posted : July 14, 2015
Last Update Posted : October 8, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The Guided Therapeutics (GTx) program at the University Health Network is a network of clinicians, scientists, and engineers focused on the development and translation of image-guided technologies focused on minimally-invasive, adaptive therapies. Technologies developed within the GTx program include a portable intra-operative cone-beam CT (in collaboration with Siemens) that has been evaluated in clinical trials for head and neck surgery. The intraoperative imaging has been integrated with tracking and navigational tools and optical imaging to provide a general "surgical dashboard" that is used to improve the accuracy of surgical resection.
A recent addition to the GTx program is the development of the GTx OR, located within the general operating room of the Toronto General Hospital. The GTx OR houses 2 complimentary advance technologies: the Siemens Zeego and the Siemens Somotom Flash CT. The dual-energy Somatom Flash provides a "gold-standard" in CT imaging, while the Zeego provides excellent 3D Cone-beam CT with robotic placement for flexible integration within the operating environment. Together, the integration of these 2 components into a single OR enables critical evaluation of the limits of CT imaging technology for surgical guidance.
This study will be conducted using solely the Cone-beam CT (Zeego) for percutaneous placement and localization of markers for resection of small pulmonary nodules during VATS.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Lung Cancer | Other: Cone Beam CT localization and placement of microcoil | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 40 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Other |
Official Title: | Cone-beam Computed Tomography (CT) Guided Microcoil Localization of Pulmonary Nodules During Video Assisted Thoracic Surgery(VATS) |
Study Start Date : | June 2015 |
Estimated Primary Completion Date : | June 2022 |
Estimated Study Completion Date : | June 2022 |

Arm | Intervention/treatment |
---|---|
Lung cancer |
Other: Cone Beam CT localization and placement of microcoil
Cone Beam CT localization and placement of microcoil |
- Radiation Exposure [ Time Frame: 4 years ]Will determine how much radiation the patient receives via CT report
- Length of time to perform procedure [ Time Frame: 4 years ]Will time the procedure in order to determine procedure length

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Any adult patient age 18 and older with lung nodules who are candidates for microcoil localization prior to VATS wedge resection
Exclusion Criteria:
- Patients that are unable to give informed consent
- Patients that are unable to tolerate general anesthesia
- Patients who are pregnant or patients that believe they are pregnant
- Patients with implantable devices susceptible to Radio Frequency (RF) fields
- Severely obese patients

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02496624
Contact: Judy McConnell | 4165817486 | judy.mcconnell@uhn.ca |
Canada, Ontario | |
University Health Network | Recruiting |
Toronto, Ontario, Canada, M5G 2C4 | |
Contact: Alexandria Grindlay 416-634-7066 alexandria.grindlay@uhn.ca | |
Contact: Judy McConnell 416-581-7486 judy.mcconnell@uhn.ca | |
Principal Investigator: Kazuhiro Yasufuku, MD, PhD |
Responsible Party: | University Health Network, Toronto |
ClinicalTrials.gov Identifier: | NCT02496624 |
Other Study ID Numbers: |
14-7395 |
First Posted: | July 14, 2015 Key Record Dates |
Last Update Posted: | October 8, 2021 |
Last Verified: | October 2021 |
Multiple Pulmonary Nodules Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms |
Neoplasms by Site Neoplasms Lung Diseases Respiratory Tract Diseases |